Abstract

Immunosuppression associated with infections of nematode parasites has been documented. Cysteine protease inhibitor (CPI) released by the nematode parasites is identified as one of the major modulators of host immune response. In this report, we demonstrated that the recombinant CPI protein of Ascaris lumbricoides (Al-CPI) strongly inhibited the activities of cathepsin L, C, S, and showed weaker effect to cathepsin B. Crystal structure of Al-CPI was determined to 2.1 Å resolution. Two segments of Al-CPI, loop 1 and loop 2, were proposed as the key structure motifs responsible for Al-CPI binding with proteases and its inhibitory activity. Mutations at loop 1 and loop 2 abrogated the protease inhibition activity to various extents. These results provide the molecular insight into the interaction between the nematode parasite and its host and will facilitate the development of anthelmintic agents or design of anti-autoimmune disease drugs.

Highlights

  • Nematode parasite infections that are highly prevalent in many parts of the world cause significant health problems [1]

  • The cDNA library of A. lumbricoides was screened by RT-PCR using the primers for consensus sequences of cystatins reported in other nematode parasites, and a fragment of the Cysteine protease inhibitor (CPI) gene was obtained

  • We investigated the structural basis of the immunomodulatory function of CPI from A. lumbricoides

Read more

Summary

Introduction

Nematode parasite infections that are highly prevalent in many parts of the world cause significant health problems [1]. Infections of these parasites are often characterized by a chronic and asymptomatic course due to the immunosuppression induced by the parasites in the hosts [2]. The nematode-induced immunosuppression is manifested as protection from autoimmune and allergic diseases [3,4]. The parasitic nematode extracts were proposed as potential therapeutic agents for treatment of autoimmune disorders and allergic diseases [8,9]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.